| |
• Rely+On infection control portfolio for the medical sector;
• Disinfection solutions combating antimicrobial resistance;
• Advanced formulations for rapid deployment;
• LANXESS booth: Messe Duesseldorf, Hall 11, #E36.
By participating in the world’s largest medical trade fair for the first time, the specialty chemicals company is emphasizing the performance of its disinfectant products portfolio in the medical sector and strengthening its presence in this segment.
Disinfection solutions against antimicrobial resistance
LANXESS will highlight its commitment to combatting antimicrobial resistance by presenting science-based disinfection solutions, including Rely+On Virkon, a globally recognized broad-spectrum disinfectant used in hospitals, medical laboratories, and public health facilities, and Rely+On PeraSafe, a leading product for the safe and rapid decontamination of medical instruments. Both products meet rigorous international standards and have demonstrated effective performance within EN efficacy testing standards, with Rely+On particularly suited for use in emergency outbreak scenarios involving SARS-CoV-2, avian influenza, norovirus, and other emerging pathogens.
Advanced formulations for rapid deployment
Alongside LANXESS will be presenting innovative, powerful active ingredients for formulators, such as Oxone (potassium monopersulfate), synthetic phenolic compounds, and aldehyde-based antimicrobials to ensure proven effectiveness and user safety. These products are designed for quick deployment to support decontamination needs in healthcare, veterinary, and transport settings. This enables institutions and authorities to respond quickly to emergencies with minimal operational disruption.
Rely+On portfolio in use on all continents
Rely+On is LANXESS’ trusted brand of high-performance disinfection products, engineered to meet the evolving needs of healthcare and institutional providers. Rely+On solutions are adopted by governments and NGOs worldwide for emergency preparedness and outbreak containment. Thanks to their favorable safety profiles, the products allow for frequent use, making them ideal for healthcare and institutional providers across the globe.
Expert consultation and latest advancements
Throughout Medica 2025 (medica-tradefair.com), LANXESS’ infection control experts will be available to showcase products, share technical expertise, and discuss the latest advancements in disinfection science. Visitors are invited to consult with specialists to receive tailored solutions addressing hospital infection prevention, emergency response, and operational safety challenges.
About LANXESS
LANXESS (lanxess.com) is a leading specialty chemicals company with sales of EUR 6.8 billion in 2019. The company currently has about 14,400 employees in 33 countries. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.
Forward-Looking Statements
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors, nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accepts any liability whatsoever arising directly or indirectly from the use of this document.
|
michael.fahrig[.]lanxess.com 
